PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.73%
Revenue growth at 50-75% of ADI's 3.07%. Martin Whitman would worry about competitiveness or product relevance.
1.31%
Gross profit growth at 50-75% of ADI's 2.48%. Martin Whitman would question if cost structure or brand is lagging.
-2.41%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-2.41%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-70.59%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-69.48%
Negative EPS growth while ADI is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-69.33%
Negative diluted EPS growth while ADI is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-3.03%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.09%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.93%
Dividend growth under 50% of ADI's 32.48%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-34.43%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-46.04%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
57.48%
10Y revenue/share CAGR at 50-75% of ADI's 104.85%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
125.75%
5Y revenue/share CAGR above 1.5x ADI's 38.93%. David Dodd would look for consistent product or market expansions fueling outperformance.
69.50%
3Y revenue/share CAGR above 1.5x ADI's 30.42%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
176.00%
10Y OCF/share CAGR above 1.5x ADI's 38.17%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
39.23%
Positive OCF/share growth while ADI is negative. John Neff might see a comparative advantage in operational cash viability.
-6.21%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
581.29%
Net income/share CAGR above 1.5x ADI's 210.98% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
765.91%
5Y net income/share CAGR above 1.5x ADI's 269.82%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
79.28%
3Y net income/share CAGR similar to ADI's 87.41%. Walter Schloss would attribute it to shared growth factors or demand patterns.
194.56%
10Y equity/share CAGR at 50-75% of ADI's 327.57%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
15.59%
Below 50% of ADI's 35.33%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
20.14%
3Y equity/share CAGR 1.25-1.5x ADI's 17.91%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
40.48%
Dividend/share CAGR of 40.48% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
37.98%
Dividend/share CAGR of 37.98% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
41.93%
3Y dividend/share CAGR of 41.93% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
8.29%
AR growth well above ADI's 0.53%. Michael Burry fears inflated revenue or higher default risk in the near future.
11.69%
Inventory growth well above ADI's 5.01%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-7.18%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-3.02%
We have a declining book value while ADI shows 1.90%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
6.34%
R&D growth drastically higher vs. ADI's 3.20%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.35%
SG&A growth well above ADI's 2.29%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.